Search research articles
Contact Us
Filters
Showing results (251-260 of 303) with videos related to
Page
of 31
Sort By:
Pharmaceutical Research
|
April 6, 2000
Hollow porous particles in metered dose inhalers
L A Dellamary, T E Tarara, D J Smith, et al.
Molecules (Basel, Switzerland)
|
May 28, 2020
Identification of Substituted Amino Acid Hydrazides as Novel Anti-Tubercular Agents, Using a Scaffold Hopping Approach
Alistair K Brown, Ahmed K B Aljohani, Fatimah M A Alsalem, et al.
Indian Journal of Pediatrics
|
November 1, 1994
A randomised multicentre study to compare the safety and efficacy of albendazole and metronidazole in the treatment of giardiasis in children
A K Dutta, M A Phadke, A C Bagade, et al.
Leukemia Research
|
July 24, 2012
Induction of differentiation and apoptosis in leukaemic cell lines by the novel benzamide family histone deacetylase 2 and 3 inhibitor MI-192
Marjorie Boissinot, Martyn Inman, Aiden Hempshall, et al.
Epilepsy Research
|
March 12, 2004
Mechanisms contributing to the exacerbated epileptiform activity in hippocampal slices of GABAB1 receptor subunit knockout mice
Jon T Brown, Catherine H Gill, Clare E Farmer, et al.
Ecotoxicology and Environmental Safety
|
June 5, 2023
Potential for cardiac toxicity with methylimidazolium ionic liquids
Tarek M Abdelghany, Shireen A Hedya, Carol De Santis, et al.
Carcinogenesis
|
January 1, 1986
7-Methylbenz[c]acridine: mutagenicity of some of its metabolites and derivatives, and the identification of trans-7-methylbenz[c]-acridine-3,4-dihydrodiol as a microsomal metabolite
J H Gill, A M Bonin, E Podobna, et al.
Stem Cells and Development
|
February 27, 2019
Human Cardiac-Mesenchymal Stem Cell-Like Cells, a Novel Cell Population with Therapeutic Potential
Rachel Oldershaw, W Andrew Owens, Rachel Sutherland, et al.
Journal of Medicinal Chemistry
|
May 5, 2017
Rationalized Computer-Aided Design of Matrix-Metalloprotease-Selective Prodrugs
Mohit Jain, J Jonathan Harburn, Jason H Gill, et al.
Molecular Pharmaceutics
|
March 20, 2014
Tumor-targeted prodrug ICT2588 demonstrates therapeutic activity against solid tumors and reduced potential for cardiovascular toxicity
Jason H Gill, Paul M Loadman, Steven D Shnyder, et al.
Page
of 31
Search research articles
Search
Showing results (251-260 of 303) with videos related to
Sort By:
Page
of 31
Pharmaceutical Research
|
April 6, 2000
Hollow porous particles in metered dose inhalers
L A Dellamary, T E Tarara, D J Smith, et al.
Molecules (Basel, Switzerland)
|
May 28, 2020
Identification of Substituted Amino Acid Hydrazides as Novel Anti-Tubercular Agents, Using a Scaffold Hopping Approach
Alistair K Brown, Ahmed K B Aljohani, Fatimah M A Alsalem, et al.
Indian Journal of Pediatrics
|
November 1, 1994
A randomised multicentre study to compare the safety and efficacy of albendazole and metronidazole in the treatment of giardiasis in children
A K Dutta, M A Phadke, A C Bagade, et al.
Leukemia Research
|
July 24, 2012
Induction of differentiation and apoptosis in leukaemic cell lines by the novel benzamide family histone deacetylase 2 and 3 inhibitor MI-192
Marjorie Boissinot, Martyn Inman, Aiden Hempshall, et al.
Epilepsy Research
|
March 12, 2004
Mechanisms contributing to the exacerbated epileptiform activity in hippocampal slices of GABAB1 receptor subunit knockout mice
Jon T Brown, Catherine H Gill, Clare E Farmer, et al.
Ecotoxicology and Environmental Safety
|
June 5, 2023
Potential for cardiac toxicity with methylimidazolium ionic liquids
Tarek M Abdelghany, Shireen A Hedya, Carol De Santis, et al.
Carcinogenesis
|
January 1, 1986
7-Methylbenz[c]acridine: mutagenicity of some of its metabolites and derivatives, and the identification of trans-7-methylbenz[c]-acridine-3,4-dihydrodiol as a microsomal metabolite
J H Gill, A M Bonin, E Podobna, et al.
Stem Cells and Development
|
February 27, 2019
Human Cardiac-Mesenchymal Stem Cell-Like Cells, a Novel Cell Population with Therapeutic Potential
Rachel Oldershaw, W Andrew Owens, Rachel Sutherland, et al.
Journal of Medicinal Chemistry
|
May 5, 2017
Rationalized Computer-Aided Design of Matrix-Metalloprotease-Selective Prodrugs
Mohit Jain, J Jonathan Harburn, Jason H Gill, et al.
Molecular Pharmaceutics
|
March 20, 2014
Tumor-targeted prodrug ICT2588 demonstrates therapeutic activity against solid tumors and reduced potential for cardiovascular toxicity
Jason H Gill, Paul M Loadman, Steven D Shnyder, et al.
Page
of 31